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Summary.-Over the past70 years many experiments have been designed to promote
tumour growth. These studies were all carried out in allogeneic tumour systems or
by artificially influencing the immunization process.
In the present study, the growth of syngeneic mammary tumour cells was en-
hanced by prior immunization via the intracaecal route. Such induced enhancement
could be transferred to untreated animals by serum or by spleen cells.
Tumour growth was also enhanced in another syngeneic system by immunization
via the intestinal route with frozen-thawed ascites tumour cells. The result is in direct
contrast to that obtained by similar immunization with live cells, which affords
protection against a later challenge.
MANY STUDIES performed over the last
70 years have been designed to elicit
tumour resistance after the injection of
inactivated tumour cells.
In several instances the results were the
opposite of those anticipated; that is,
tumour growth was promoted rather than
inhibited by prior immunization.
The phenomenon of enhancement was
first observed by Flexner and Jobling
(1907) who found that the growth of a
transplantable sarcoma in rats was en-
couraged if the hosts had been given a
prior injection of tumour cells heated for
half an hour at 56°C. The effect was pro-
nounced when the heated tumour cells
were injected s.c. several times before
challenge with live cells.
A great many studies have since been
made. These early experiments were
repeated and confirmed by Snell et al.
(1946) and Snell (1970). Kaliss (1952, 1958)
passively transferred this specific tumour
susceptibility with serum from treated
animals. He called the phenomenon "im-
munological enhancement", defining it as
the successful establishment of a tumour
homograft and its progressive growth as a
consequence of the tumour's contact with
specific antiserum in the host. Kaliss
leaves no doubt that specific antibodies
play a fundamental role in the induction of
enhancement. He worked, however, with
allogeneic tumours. It has been extremely
difficult to reproduce this phenomenon
with syngeneic tumours. By changing the
test system, however, Moller (1964) found
that treatment with immune serum en-
hanced the growth of chemically induced
syngeneic murine sarcomas.
Attia and Weiss (1966) were also able to
enhance the growth of spontaneous mam-
mary carcinomas by pretreatment with
tumour cell-membrane concentrate, but
only if the first inoculation was given in
complete Freund's adjuvant.
Takasugi and Hildemann (1969) found,
when antiserum fractions were tested in
vivo, that only IgGy2 was capable of
enhancing tumour growth.
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In accordance with this, Ran and XVitz
(1972) reported that IgG2-containing elu-
ates were able to enhance the growth of
syngeneic tumours.
If enhancement is important in limiting
host resistance to autochthonous tumours,
it is most important to understand the
mechanisms, so that attempts can be made
to redirect immune responses to the
production of more valuable classes of
immune substances.
In 1957 Lund reported that rats treated
with intracaecal injections of Yoshida's
ascites tumour cells developed resistance
to the secondary challenge with this
tumour. Theprotective effectofintracaecal
injections of malignant ascites cells was
confirmed by our results (Laursen and
Laursen, 1977). In further studies we have
also found that growth of a subsequient
graft could be enhanced in this way.
The present report describes the en-
hancement of growth of spontaneous
syngeneic mammary carcinoma cells by
prior immunization via the intracaecal
route with the same cells, without other
treatments.
Enhancement of tumour growth is also
induced in another syngeneic system by
immunization via the intestinal route with
frozen-thawed ascites tumour cells, and
this increased tumour susceptibility is
passively transferred with serum and
spleen cells to untreated animals. This is
in direct contrast to our results (Laursen
and Laursen, 1977) obtained by immuniza-
tion in the same way, but with live cells,
where protection was afforded against a
later challenge.
MATERIALS AND METHODS
Eight- to 10-wieek-old inbred mice of the
C3H-Fib strain were used for this work. The
animals were kept under conventional condi-
tions with up to 10 mice in each cage. The
mice were maintained on a standard pellet
diet and water ad libitumn.
Malignant material of two types was used.
One was a spontaneous mammary carcinoma
which originated in a C3H-Fib mouse and -was
passed serially by the s.c. route. The experi-
ments wTere carried out wsith the 6tlh to 18th
transfergenerations. The adenocarcinomatous
nature of the tumour cells was confirmed by
histological examination, and their im-
munogenecity tested as described in Table I.
To prepare a single-cell suspension, the
solid tumour wAas first cut wvith scissors and
then disrupted in a loose-fitting Braun-
Melsungen glass homogenizer. The cell sus-
pension wvas placed in a test tube, and after
sedimentation for 15-20 min, the single cells
in the supernatant wvere counted in a Burger-
Turk's haemocytometer. Trypan-blue exclus-
ion showed a viability > 80%.
This test was used for the experiments
reported here. The cells were suspended in
PBS to obtain the desired count in 0-1 ml. In
connection with immunofluorescence investi-
gations, however, a fluorescein-conjugated
anti-mouse gammaglobulin stain revealed
the homogeneous reaction characteristic of
dead cells in ~400
' ofsingle cells prepared in
this wA,ay. The two measures of cell viability
were not concordant, wAhich means that the
viability for cells used in the experiments was
not really known.
The other malignant cell line used for this
work was derived from cultures ofC3H mouse
lung fibroblasts which had undergone appar-
ently spontaneous malignant conversion and
transformation during propagation in vitro.
Fronm these cells an ascites tumour (C3H-1,l/a)
was established which grew equally well in
vivo and in vitro.
The caecum in the mouse represents a
convenient target for injection of cells, since
it is relatively large and quite mobile.
Immunization by this route required a small
laparotomy whereby the caecum was drawn
outside the abdominal cavity. The desired
cell number in a volume of 0-1 ml was
inoculated into the caecal lumen of ether-
anaesthesized mice with a small injection
needle (27G x 1).
Tumour volumes were estimated from the
formula, V = 0 4 ab2, where a is the major
diameter and b the minor diameter, as pro-
posed by Attia and Weiss (1966).
Treatment of ascites cells with mitomycin
C was done in vitro. Mitomycin C wvas dis-
solved in PBS at 2 mg/ml. For every 5 x 107
cells, 0-25 ml of this solution was used. The
ascites cells w%vere incubated at 37°C with
gentle stirring for 2 h and then washed in
PBS.
For experiments with adoptive transfer of
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serum or cells, the donor mice were bled from
the retro-orbital sinus 2 weeks after the last
immunization. The blood was left to coagulate
at room temperature. The clot was carefully
detached from the glass and removed by
centrifugation. From the pooled serum,
0-2 ml was given i.p. to each recipient and the
rest of the serum was stored at -20°C. After
bleeding, the mice were killed by cervical
dislocation. Spleens, mesenterial, inguinal and
axillary lymph nodes were dissected free, cut
with scissors and disrupted in a loose-fitting
glass homogenizer. The cells were washed
twice and resuspended in PBS.
RESULTS
The mammary tumour used developed
spontaneously in a C3H mouse and its
immunogenicity was tested as described
in Table I. After removal of the first
TABLE I.-Immunogenicity of the Mam-
mary Tumour
Tumour volume (cm3)
(Mean+s.d.) A
Time after challenge 27 days 36 days
10pre-immunizedmice 0*79±0*42 0*88±0-36
9 non-immunized mice 1.24±0*26 1*91±0I43
C3H mice had 5 x 106 mammary tumour cells
transplanted to the right flank, and all developed
small tumours which were excised after 14 days. One
week later the animals were given a new transplant
of 5 x 106 ofthe same mammary tumour cells to the
left flank, and the tumour size was measured after 27
and 36 days.
According to the Mann- Whitney rank-sum test
the groups differ significantly at the 95% level after
27 days and at the 98% level after 36 days.
transplant, the animals rested for one
week. They were then given a new trans-
plant to the opposite flank and the
tumours were measured 27 and 36 days
later. In half the group, local recurrence
was observed after the first transplant.
These mice showed the greatest resistance
to the second transplant. For the whole
group a mean tumour volume of 0-88 cm3
was calculated after 36 days, as against
1-91 cm3 for the untreated group. At that
time, tumour growth in the 2 groups
differed significantly at the 98% level.
The s.c. inoculation of mammary tumour
TABLE II.-The Effect of Immunization of
C3H Mice by the Intracaecal (i.c.) Route
with 5x 106 Syngeneic Mammary Tum-
our Cells against an s.c. Challenge 2
Weeks Later with the Same Amount of
the Same Tumour Cell
Tumour volume (cm3)
(Mean±s.d.)
Immunization No. mice 18 days 27 days
I.c. x 1 20 0-42±0-26 1-91±0-46
I.c. x 2 14 1 27±0 41 3 40±1 08
Non-immunized 17 0*51±1-0*21 1*62±0*38
controls
According to theMann-Whitney rank-sum test the
group immunized twice differs significantly from the
non-immunized group, even at the 99% level.
cells had elicited a protective response,
whereas after 2 intracaecal immunizations
we found the opposite effect, as recorded
in Table II. Immunization twice with a
one-week interval by inoculation into the
caecal lumen actually enhanced tumour
growth of a transplant inoculated s.c. 2
weeks later. After 27 days, a mean tumour
volume of 3 40 cm3 was recorded in the
immunized group, while tumours in the
non-immunized group had only grown to a
mean of 1P62 cm3. A single inoculation of
mammary tumour cells into the caecal
lumen did not affect the growth of a
subcutaneous tumour.
Table III shows the results of experi-
ments where enhancement was adoptively
transferred to untreated C3H mice with
serum or spleen cells from C3H mice
immunized twiceintracaecally (with a one-
week interval) with mammary tumour
cells.
By transferring 0-2 ml serum 1 h before
the s.c. challenge and again 2 and 4 days
later, tumour growth was enhanced; a
mean tumour volume of 2-32 cm3 was
recorded 27 days later, whereas tumours
in the untreated group hadgrown only to a
mean of 1-37 cm3. A stronger enhancement
wasnoticed aftertransfer ofspleen cells 1 h
before challenge. The s.c. transplant in
this group then grew to a mean volume of
3 09 cm3, which may again be compared
with the aforementioned 1'37 cm3 for
controls.
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TABLE III.-The Adoptive Transfer of Enhancement by Serum and Spleen Cells
Transfer of
Serum*
108 spleen cells
108 axillary and inguinal
lymphode cells
Untreated controls
Tumour volume (cm3)
(Mean±s.d.)
No. of ,A-- mice 18 days 27 days
7 0 99i0 35 2.320±0.71a
10 1 08±0-27 3.09±0.70a
8 0-34±0-12 1-14±0-32
10 0-45+0-18 1-37±0-29
* A serum volume of 0 -2 ml/mouse was given 1 h before challenge and
again 2 and 4 days later.
a These groups differ significantly at the 95% level from the controls,
according to the Mann-Whitney rank-sum test.
Donors: C3H mice immunized intracaecally twice with 5 x 10f mam-
mary tumour cells, with a one-week interval, and killed after another 2
weeks.
Recipients are C3H mice receiving serum or cells i.p. and 1 h laterchal-
lenged s.c. with the same amount of the same tumour cells used for the
immunization of the donors.
Transference of axillary an(
lymphnode cells caused a s
insignificant inhibition of tumoi
The group which received i
lymphnode cells i.p. died a few (
The lymphnode cells must I
contaminated during the prepar
Analogous results with C3H
munized with a frozen-thawed
line are presented in Tables IV-
We have earlier (1977) rep
protective effect of immunizin
intracaecal route with the sam
ascites cells.
Table IV shows the effect of 1
thawed cells inoculated either
TABLE IV.-The Effect ofImmui
C3H Mice with 1O7Frozen-thau
Cells by either the Intracaeca
s.c. Route against an i.p. Tra
107 Live Ascites Cells 14 days j
Immunization
I.c. x 1
I.c. x 2
S.c. x 1
S.c. x 2
Untreated
Sham-operated
Dead/total
8/8
16/16
8/9
2/9b
20/20
10/10
Su
(M
a Significantly different (95% lev
Whitney test) from untreated control.
b Significantly different (Fourfold tes
treated control.
I inguinal caecal lumen (i.c.) or s.c. with a later i.p.
light but transplant of 107 live cells. A single dose of
ur growth. frozen-thawed ascites cells, either i.c. or
mesenteric s.c., does not significantly affect the
days later. survival of the C3H mice after challenge.
iave been In the group immunized twice i.c.,
ation. survival after challenge decreased to a
mice im- mean of 16 days, compared with a 23-day
ascites cell mean survial time for the non-immunized
VI. animals.
orted the In the group immunized twice s.c. 78%
ig by the survivedthe challenge, while all miceinthe
e but live control group died. Significant protection
was afforded.
L07 frozen- Table V records the effect of adoptive
into the transfer of serum, spleen and lymphnode
cells from donors immunized twice, either
s.c. or i.c. to untreated C3H mice on a izatiton of simultaneous transplant of 107 live ascites sedAscites cells.
nl (i.c.) or From donors immunized s.c., transfer of
nsplant of spleen cells, lymphnode cells or serum does ti~ater not affect the hosts' survival after a
rvivalafter simultaneous challenge, whereas transfer challenge of spleen cells from i.c.-immunized donors
(in days) mrel
[ean±s.d.) markedly shortened the survival after
20±2-7 challenge. The group that received spleen 16±3- a cells and ascites cells i.p. died 15 days 25-+12-5 later, whilst mice in the control group
23±2-8 survived the dose of ascites cells and non-
24±2 1 sensitized spleen cells for an average of 22
vel. Mann-- days. Treatment with 0-2 ml of serum
t) from un- from C3H mice immunized twice i.c. with
frozen-thawed ascites cells does affect
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TABLE V.-The Effect of Adoptive Transfer to Untreated C3H Mice ofSpleen Cells and
Seritm from Donors Immnunized Twice with 107 Frozen-thawed cells either s.c. or i.c.
on a Simultaneous i.p. Transplant of 107 Live Ascites Cells
I.p. transfer of:
S.p. immunize(l (lonors 15 x 107spleen cel
15 x 107 lymphode
0* 2 ml pooled serur
I.e. immunize(l (lonors 15 x 107 spleen cel
0 2 ml pooled serur
Non-immunizedl (lonors 15 x 107 spleen cells
a Significantly (different (99/,, level AMann-
significant.
Survival for
Dead within tumouir takes (days)
:3 month/group x s
6/10 20±2-6
9/10 23±1-9
7/10 23 2-7
9/9
6/6
15±2?3a
1S±-2-4
22±2- I
-Whitney test) from Control. No other groups
somewhat, though nol
survival after a simul
of live cells. This grour
days earlier than the cc
However, not only
frozen-thawedcellsenhc
but, as Table VI shows
after two i.c. inoculat
C-treated cells (thoup
still protect against a 1
Necropsy of anima
mammary tumour ce
lumen revealed tumoui
intestinal epithelium
TABLE VI. Enhanc1ne?
by Inoculation into
Twice with One 1free
Frozen-thawed C3HL
mycin-C-treated C31
C3H Mice were Chall
with 107Live Ascites
N
tuirr
Frozen-thawed cells into
caecum
Mitomycin-C-treated
cells into caecum
Sham-operated non-
immunized controls
Live ascites cells into
caecum
Times of survival in the
significantly from the non-iI
level, Manni---Whitney text).
t significantly, the
taneous transplant
? died on average 4
ntrol group.
do i.c.-inoculated
ancetumourgrowth
3, this also happens
colon of 3/34 mice. No mice similarly
inoculated with ascites cells had tumours
growing in the intestinal wall.
DISCUSSION
ions of mitomvein In a previous report (1977) the authors
yh untreated cells showed that inoculation of live malignant
ater i.p. challenge). ascites cells into the caecal lumen pro-
Js which received duces a protective effect against a second-
lls in the caecal ary i.p. challenge with the same tumour
rs implanted in the cells. The protection could be transferred
of the caecum or to untreated animals by sensitized spleen
cells. To obtain such an immunization, the
ascites cells from the caecal lumen must
ntofTumour Growth have invaded the intestinal epithelium and
the Coecal Lumen established contact with lymphoid tissue.
,k's Interval of 107 One of the basic characteristics of
,l/a Cells or Mito- malignant tumour cells is, however, their
J-Ll/a Cellls. The ability to infiltrate or invade surrounding
enged 3 Weeks Later normal tissues. That the malignant ascites
Cells i.p. cells used for this work have such an
ability seems likely, since an i.p. ascites
To. mice Time of tumour was developed in C3H mice with
withl survival impaired immune capacity after inocula- iouir/total (cays)
tion of live ascites cells into the colonic
26/26 20 0 1 8 lumen through a small rectal probe,
12/12 21 -3± 1 leaving the intestinal epithelium intact (to
be published in detail). 10/14 27-3 2-6-9 t In the present study we have dealt with
1/12 the possibility of enhancing tumour
growth by prior immunization via the
first two groups differ intestine. mmuinized group (0 An important finding was that 2
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inoculations of mammary carcinoma cells
into the caecal lumen enhanced the
growth of a later s.c. challenge with the
same cells in syngeneic C3H mice.
That enhancement induced in this way
could be transferred by serum to untreated
animals indicates that we are dealing with
immunological enhancement as originally
defined by Kaliss (1958). The ability of
spleen cells to transfer enhancement does
not contradict the definition of the
phenomenon in question, since specific
antibodies could be determined in serum
from animals receiving sensitized spleen
cells, indicating that some spleen cells are
primed antibody-producing cells (to be
published).
Inoculated s.c., the mammary tumour
cells caused the opposite immune reaction,
since the growth of a later transplant was
inhibited.
That at least 2 different immune
reactions are inducible by intestinal im-
munization can be more clearly inferred
from our work with the malignant ascites
cell.
By immunizing with live ascites cells
via the intracaecal route a protective
immune reaction is obtained and the
protective effect can be transferred to
untreated animals by spleen cells.
In the present study the same ascites
cells were used, but the cells were frozen
and thawed 5 times before caecal inocula-
tion. By this change (from live to frozen-
thawed cells) the very opposite immune
reaction appeared. The i.p. tumour grew
faster in mice immunized twice with
frozen-thawed cells thaninnon-immunized
mice.
An s.c. immunization conferred protec-
tion whether live cells or frozen-thawed
cells were used. It seems unlikely that an
alteration ofmembrane antigen byfreezing
and thawing the ascites cells enhanced
tumour growth, since enhancement also
could be induced by mitomycin-C-treated
cells. More likely is the assumption that the
different immune reactions obtained by
immunization via the intracaecal route are
(lue to in(luction of immunity in (lifferent
lymphoid cells whether live or treated cells
are used.
Purdom, Ambrose and Kleini (1958)
found, in sublines of ascites sarcoma cells,
a direct correlation between the negative
surface charge of the cells, as indicated by
migration in an electric field, and the
degree of invasiveness exhibited in the
animal. The ascites form had the hiighest
electrophoretic mobility, whilst the solid
line ofthe tumour had the lowest.
In the present study, the live ascites cell
should then be best able to migrate into
the intestinal wall, and might even leave
this wall via the efferent lymphatics.
Frozen-thawed cells and mitomycin-C-
treated cells, however, do not have this
ability to the same degree. As the distribu-
tion ofIg-containing cells is not homogene-
ous throughout the depth of the intestinal
wall, it is rendered probable that the
immune response differs according to
whether sensitization takes place in the
mesenteric lymph node, deep in the
intestinal wall or in lymphoid cells placed
near the lumen.
According to such hypotheses, en-
hancement should be induced in the
intestinal wall by the most luminally
placed components ofthe immune system.
The mammary tumour cells (MTC)
originated as a solid tumour and, accord-
ing to the findings by Purdom et al. (1958),
had a lesser ability to migrate than had the
live ascites cells. Furthermore, the MTC
suspension used in this study was a
mixture of live and dead cells. By im-
munizing with this suspension a balanced,
or at least partially balanced response
should result. In our experiments, the
enhancing effect dominated.
The -work cariiedl out at the Fibiger Laboratory
was sponsored by the Danish Cancer Society.
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